HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
COVID-19 Outbreak Tracker hones in on hotspots
Digital Checkup

COVID-19 Outbreak Tracker hones in on hotspots

8:39

Cotiviti leverages claims and clinical data for payers to use and share with providers, explains President and CEO Emad Rizk, MD.

Read More
Read Less

Digital Checkup - Similar Videos View more in Digital Checkup

8:16

States are pressed to show progress under RHTP

Continued funding from the federal Rural Health Transformation Program requires integrated data across providers. Making it easy for them to connect virtually to state systems is vital, says Dr. Tim Ferris, InterSystems' VP of healthcare practice.

States are pressed to show progress under RHTP
Continued funding from the federal Rural Health Transformation Program requires integrated data across providers. Making it easy for them to connect virtually to state systems is vital, says Dr. Tim Ferris, InterSystems' VP of healthcare practice.
8:16
7:34

Why AI is a great partner for better care delivery

According to Michael Meucci, Arcadia's president and CEO, marrying data about patients, care journeys, costs and more for AI to analyze can uncover utilization signals that providers and payers can use to enhance care delivery.

Why AI is a great partner for better care delivery
According to Michael Meucci, Arcadia's president and CEO, marrying data about patients, care journeys, costs and more for AI to analyze can uncover utilization signals that providers and payers can use to enhance care delivery.
7:34
7:30

PBM reform moves the system from a rebate structure to flat fees

The legislation will give greater insight into the cost of therapies, but it doesn't mean premiums or the price of drugs will go down, says Ryan Czado, chief pharmacy officer of RazorMetrics.

PBM reform moves the system from a rebate structure to flat fees
The legislation will give greater insight into the cost of therapies, but it doesn't mean premiums or the price of drugs will go down, says Ryan Czado, chief pharmacy officer of RazorMetrics.
7:30